Evidence Synthesis
JBCHEPHARM's 67.77% gross margin accelerated, up from 16.48%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 3 Sept 2026, 01:23
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
JBCHEPHARM's 67.77% gross margin accelerated, up from 16.48%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 67.77 % | 16.48 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 16.48 % | 17.11 | ▼ |
| REVENUE_GROWTH_YOY | -4.8 % | -31 | ▲ |
| EPS_ACTUAL | 12.75 INR | 13.08 | ▼ |
| EPS_SURPRISE_PERCENT | -0.063 % | 0.014 | ▼ |
| PRICE_CHANGE_PERCENT | 0.299 % | — | - |
| DAILY_VOLUME | 47,79,224 shares | 4,33,835 | ▲ |
| CLOSE_PRICE | 2,416.1 INR | 2,408.9 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.88 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 2 count | 5 | ▼ |
| TARGET_PRICE_PREMIUM | -3.64 % | — | - |